IDRA NASDAQ
Idera Pharmaceuticals, Inc.
1W: -35.1%
1M: +51.7%
3M: +14.2%
1Y: -39.3%
3Y: -77.5%
5Y: -97.9%
$0.42
Last traded 2023-01-17 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$28M
-0.5% ▼
Net Income
-$23M
-123.8% ▼
EPS (Diluted)
$-7.18
-122.8% ▼
EBITDA
-$28M
-128.4% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $662K | $1M | $0 | $0 | $0 |
| YoY Growth | -26.6% | +118.7% | -100.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $662K | $1M | $0 | $0 | $0 |
| Gross Margin | 100.0% | 100.0% | — | — | — |
| R&D Expenses | $42M | $35M | $25M | $16M | $12M |
| SG&A Expenses | $15M | $12M | $12M | $10M | $12M |
| Operating Expenses | $57M | $47M | $37M | $28M | $33M |
| Operating Income | -$61M | -$46M | -$37M | -$28M | -$28M |
| Operating Margin | -9207.9% | -3181.4% | — | — | — |
| Interest Expense | $11K | $0 | $3K | $7K | $204K |
| Income Before Tax | -$60M | -$85M | -$113M | $98M | -$30M |
| Tax Expense | $0 | -$10M | $0 | $7K | -$6M |
| Net Income | -$60M | -$85M | -$113M | $98M | -$23M |
| Net Margin | -9045.5% | -5839.6% | — | — | — |
| EPS (Diluted) | $-38.27 | $-33.66 | $-56.63 | $31.55 | $-7.18 |
| EBITDA | -$59M | -$56M | -$113M | $98M | -$28M |
| Shares Outstanding | 2M | 2M | 2M | 3M | 3M |